NicotinamideNicotinamide
specialty
别名: Nicotinamide (high-dose oral), Vitamin B3 (oral oncology dose)
About
Nicotinamide at chemoprevention doses replenishes cellular NAD+ depleted by UV-induced PARP activation, enhancing cellular energy for DNA repair. The landmark ONTRAC trial (386 patients, NEJM 2015) found nicotinamide 500 mg twice daily reduced new nonmelanoma skin cancers by 23% and actinic keratoses by 11% in high-risk individuals.
How It Works
Amide form of vitamin B3 (distinct from niacinamide in dosing context); replenishes cellular NAD+ depleted by UV-induced PARP activation; enhances cellular energy for DNA repair; supports immune surveillance of skin cancer precursors; strengthens skin barrier ceramide synthesis.
Evidence For Conditions
| 健康状况 | 等级 | 研究数量 | 受试者 | |
|---|---|---|---|---|
| UV Protection (Internal Photoprotection) | A | 5 | 686 | 查看 → |
Side Effects
- Generally well-tolerated (no flushing)
- Mild gastrointestinal discomfort at high doses
- Rare hepatotoxicity at very high doses
Drug & Supplement Interactions
- Anticonvulsants (carbamazepine — may increase levels)
- Isoniazid (competes for NAD+ pathways)
- Hepatotoxic drugs (potential additive liver effect at high doses)
请务必告知您的医疗保健提供者您正在服用的所有补充剂。
Related Ingredients
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。